E9034
Phosphodiesterase 5A1 human
recombinant, expressed in Sf9 cells
Synonyme(s) :
3′,5′-cyclic-GMP phosphodiesterase, PDE 5A1
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
| Conditionnement | Référence | Disponibilité | Prix |
|---|---|---|---|
| 10 μg | Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit. | 879,00 $ |
879,00 $
Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderrecombinant
expressed in Sf9 cells
Quality Segment
form
solution
specific activity
≥2,000 unit/μg protein
mol wt
126 kDa
UniProt accession no.
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... PDE5A(8654)
General description
N-terminal GST-tagged 126 kDa full-length protein
Research area: Cell SignallingPDE5is located in various tissues such as the kidney, brain, lungs, cardiac myocytes,vascular smooth muscle cells, penile corpus cavernosum, platelets, andgastrointestinal tissues.[1]
Biochem/physiol Actions
PDE5 regulates vascular smooth muscle contraction and is involved in NO-cGMP signaling in platelets to control aggregation. PDE5 may also be involved in the regulation of cGMP signaling in the brain and may modulate pressure-induced cardiac hypertrophy and fibrosis [2]. Phosphodiesterase (PDE)is an enzyme that is used to break phosphodiester bonds. Phosphodiesterase 5 (PDE5), amolecular target for the treatment of erectile dysfunction and pulmonaryhypertension. PDE5 is used to find novel PDE5 inhibitors. PDE5 specifically targets cyclicguanosine monophosphate (cGMP) generated by the activation of nitric oxide (NO). PDE5 regulates cGMP signalingin the cardiovascular and other tissues. At the genetic level PDE5 isexpressed as various isoforms and undergoes phosphorylation as a post-translationalmodification that results in its activation. PDE5 is degraded through theubiquitin pathway due to its nitrosylation.[1]
Physical form
Supplied as a solution in 20% glycerol containing 40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, 0.04% TWEEN® 20 and 3 mM DTT
Other Notes
One unit will convert 1.0 picomole of 3′,5′-cGMP to 5′-GMP per minute at pH 7.4 at 37 °C.
Legal Information
TWEEN is a registered trademark of Croda International PLC
1 of 1
Cet article | |||
|---|---|---|---|
| Gene Information human ... PDE5A(8654) | Gene Information human ... PDE5A(8654) | Gene Information human ... PDE5A(8654) | Gene Information human ... PDE5A(8654) |
| specific activity ≥2,000 unit/μg protein | specific activity - | specific activity - | specific activity - |
| form solution | form buffered aqueous solution | form buffered aqueous glycerol solution | form buffered aqueous glycerol solution |
| recombinant expressed in Sf9 cells | recombinant - | recombinant - | recombinant - |
| UniProt accession no. | UniProt accession no. | UniProt accession no. | UniProt accession no. |
| shipped in dry ice | shipped in dry ice | shipped in wet ice | shipped in wet ice |
Classe de stockage
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Numéro d'article de commerce international
| Référence | GTIN |
|---|---|
| E9034-10UG | 04061838163325 |